Form 4 for CMMB Chemomab Therapeutics Ltd.

Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-18 · accession 0001178913-22-001181 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-03-21	2022-03-18	CMMB	Maryles Joel Michael	Dir	P - Purchase	$4.34	+1,000	500	New	+$4,340
DM	2022-03-21	2021-04-19+	CMMB	Maryles Joel Michael	Dir	A - Grant	$0.00	+18.7K	11.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	American Depositary Shares	2022-03-18	P	A	500	$4.36	1,000	D	—	—	(F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
2	Common	American Depositary Shares	2022-03-18	P	A	500	$4.32	500	D	—	—	(F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
3	Derivative	Option to Purchase American Depositary Shares	2022-03-07	A	A	6,820	$0.00	6,820	D	$3.53 · — to 2032-03-07	6,820 American Depositary Shares	(F2) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F3) These options vest and become exercisable in their entirety on March 16, 2023.
4	Derivative	Option to Purchase American Depositary Shares	2021-04-19	A	A	11,884	$0.00	11,884	D	$27.26 · — to 2031-04-19	11,884 American Depositary Shares	(F2) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F4) These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.